Laserfiche WebLink
6 <br /> <br />3. “Naloxone Plus” strategies, which work to ensure that individuals who <br />have received naloxone to reverse the effects of an overdose are then <br />linked to treatment programs or other appropriate services; <br />4. Officer prevention strategies, such as the Law Enforcement Assisted <br />Diversion (“LEAD”) model; <br />5. Officer intervention strategies such as the Leon County, Florida Adult <br />Civil Citation Network or the Chicago Westside Narcotics Diversion to <br />Treatment Initiative; or <br />6. Co-responder and/or alternative responder models to address OUD-related <br />911 calls with greater SUD expertise. <br />2. Support pre-trial services that connect individuals with OUD and any co- <br />occurring SUD/MH conditions to evidence-informed treatment, including <br />MOUD, and related services. <br />3. Support treatment and recovery courts that provide evidence-based options for <br />persons with OUD and any co-occurring SUD/MH conditions. <br />4. Provide evidence-informed treatment, including MOUD, recovery support, harm <br />reduction, or other appropriate services to individuals with OUD and any co- <br />occurring SUD/MH conditions who are incarcerated in jail or prison. <br />5. Provide evidence-informed treatment, including MOUD, recovery support, harm <br />reduction, or other appropriate services to individuals with OUD and any co- <br />occurring SUD/MH conditions who are leaving jail or prison or have recently left <br />jail or prison, are on probation or parole, are under community corrections <br />supervision, or are in re-entry programs or facilities. <br />6. Support critical time interventions (“CTI”), particularly for individuals living with <br />dual-diagnosis OUD/serious mental illness, and services for individuals who face <br />immediate risks and service needs and risks upon release from correctional <br />settings. <br />7. Provide training on best practices for addressing the needs of criminal justice- <br />involved persons with OUD and any co-occurring SUD/MH conditions to law <br />enforcement, correctional, or judicial personnel or to providers of treatment, <br />recovery, harm reduction, case management, or other services offered in <br />connection with any of the strategies described in this section. <br />E. ADDRESS THE NEEDS OF THE PERINATAL POPULATION, CAREGIVERS, <br />AND FAMILIES, INCLUDING BABIES WITH NEONATAL OPIOID <br />WITHDRAWAL SYNDROME. <br />Address the needs of the perinatal population and caregivers with OUD and any co- <br />occurring SUD/MH conditions, and the needs of their families, including babies with